BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9578091)

  • 21. [Preliminary research of the relationship between overexpression of facilitative glucose transporter-1 and fluorodeoxyglucose uptake in primary human lung squamous cell carcinoma].
    Wang T; Sun YE; Tian JH; Liu XB; Yao SL; Wang K
    Zhonghua Wai Ke Za Zhi; 2003 Dec; 41(12):913-6. PubMed ID: 14728832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The value of calretinin and cytokeratin 5/6 as markers for mesothelioma in cell block preparations of serous effusions.
    Shield PW; Koivurinne K
    Cytopathology; 2008 Aug; 19(4):218-23. PubMed ID: 17916095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical expression of human erythrocyte glucose transporter and fatty acid synthase in infiltrating breast carcinomas and adjacent typical/atypical hyperplastic or normal breast tissue.
    Alò PL; Visca P; Botti C; Galati GM; Sebastiani V; Andreano T; Di Tondo U; Pizer ES
    Am J Clin Pathol; 2001 Jul; 116(1):129-34. PubMed ID: 11447743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GLUT1 antibody staining in thin-layer specimens of benign and malignant body cavity effusions.
    Mensch LS; Weller L; Simmons-Arnold L; Gibson PC; Leiman G; Beatty B
    Acta Cytol; 2002; 46(5):813-8. PubMed ID: 12365212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic utility of calretinin immunohistochemistry in cytologic cell block preparations.
    Wieczorek TJ; Krane JF
    Cancer; 2000 Oct; 90(5):312-9. PubMed ID: 11038429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GLUT1 glucose transporter expression in benign and malignant thyroid nodules.
    Haber RS; Weiser KR; Pritsker A; Reder I; Burstein DE
    Thyroid; 1997 Jun; 7(3):363-7. PubMed ID: 9226204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glut3 expression in biopsy specimens of laryngeal carcinoma is associated with poor survival.
    Baer S; Casaubon L; Schwartz MR; Marcogliese A; Younes M
    Laryngoscope; 2002 Feb; 112(2):393-6. PubMed ID: 11889403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of cell cycle proteins in ovarian carcinoma cells in serous effusions-biological and prognostic implications.
    Davidson B; Risberg B; Berner A; Nesland JM; Tropé CG; Kristensen GB; Bryne M; Goscinski M; van de Putte G; Flørenes VA
    Gynecol Oncol; 2001 Nov; 83(2):249-56. PubMed ID: 11606079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of facilitative glucose transporters in gastric tumors.
    Noguchi Y; Marat D; Saito A; Yoshikawa T; Doi C; Fukuzawa K; Tsuburaya A; Satoh S; Ito T
    Hepatogastroenterology; 1999; 46(28):2683-9. PubMed ID: 10522065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of the GLUT1 glucose transporter in gallbladder carcinomas.
    Kim YW; Park YK; Yoon TY; Lee SM
    Hepatogastroenterology; 2002; 49(46):907-11. PubMed ID: 12143238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of glucose transporter 1 expression in patients with hypopharyngeal carcinoma.
    Mineta H; Miura K; Takebayashi S; Misawa K; Araki K; Misawa Y; Ueda Y
    Anticancer Res; 2002; 22(6B):3489-94. PubMed ID: 12552944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. nm23 is expressed in reactive mesothelium and is not useful for detection of malignant cells in serous effusions.
    Zimmerman RL; Fogt F
    Oncol Rep; 2006 Jan; 15(1):85-8. PubMed ID: 16328038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methyl-beta-cyclodextrin stimulates glucose uptake in Clone 9 cells: a possible role for lipid rafts.
    Barnes K; Ingram JC; Bennett MD; Stewart GW; Baldwin SA
    Biochem J; 2004 Mar; 378(Pt 2):343-51. PubMed ID: 14616090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significance of pericellular lacunae in cell blocks of effusions.
    Price BA; Ehya H; Lee JH
    Acta Cytol; 1992; 36(3):333-7. PubMed ID: 1580117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of the GLUT1 glucose transporter, p63 and p53 in thyroid carcinomas.
    Kim YW; Do IG; Park YK
    Pathol Res Pract; 2006; 202(11):759-65. PubMed ID: 17029809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunocytochemical panel for distinguishing between carcinoma and reactive mesothelial cells in body cavity fluids.
    Politi E; Kandaraki C; Apostolopoulou C; Kyritsi T; Koutselini H
    Diagn Cytopathol; 2005 Mar; 32(3):151-5. PubMed ID: 15690338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression and localisation of GLUT1 and GLUT12 glucose transporters in the pregnant and lactating rat mammary gland.
    Macheda ML; Williams ED; Best JD; Wlodek ME; Rogers S
    Cell Tissue Res; 2003 Jan; 311(1):91-7. PubMed ID: 12483288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of immunolocalization of CD57 and GLUT-1 in cell blocks in fine-needle aspiration diagnosis of papillary thyroid carcinoma.
    Chandan VS; Faquin WC; Wilbur DC; Khurana KK
    Cancer; 2006 Oct; 108(5):331-6. PubMed ID: 16944537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of the human erythrocyte glucose transporter occurs as a late event in human colorectal carcinogenesis and is associated with an increased incidence of lymph node metastases.
    Younes M; Lechago LV; Lechago J
    Clin Cancer Res; 1996 Jul; 2(7):1151-4. PubMed ID: 9816281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GLUT1 immunoreaction patterns reliably distinguish hemangioblastoma from metastatic renal cell carcinoma.
    North PE; Mizeracki A; Mihm MC; Mrak RE
    Clin Neuropathol; 2000; 19(3):131-7. PubMed ID: 14606586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.